Analytical Data
-
Gene name
EEF1A1
- Application
-
Alternative Names
CCS-3; CCS3; EEF-1; EEF1A; EF-Tu; EF1A; FLJ25721; GRAF-1EF; LENG7; PTI1; eEF1A-1; Leukocyte Receptor Cluster(LRC)Member 7; Elongation factor Tu
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P68104
-
Expression Region
Met1~Pro241
-
Molecular Weight
30kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EEF1A1, or Eukaryotic Translation Elongation Factor 1 Alpha 1, is a crucial protein involved in the process of protein synthesis, specifically in the elongation phase of translation. It plays a significant role in the binding of aminoacyl-tRNAs to the ribosome, thereby facilitating the assembly of polypeptides in response to mRNA instructions. Recent studies have spotlighted EEF1A1 not only for its essential function in translation but also for its involvement in various cellular processes, including cell signaling, stress response, and apoptosis. Beyond its traditional role, EEF1A1 has been implicated in cancer biology, with research indicating that its overexpression may be correlated with tumor growth and metastasis. This has prompted further investigations into its potential as a therapeutic target and a biomarker for cancer diagnosis and prognosis. Experimental approaches involving the recombination of EEF1A1 have yielded insight into its structural properties and functional mechanisms, paving the way for innovative applications in drug development. Understanding the multifaceted roles of EEF1A1 could ultimately contribute to advancing therapeutic strategies against various diseases, particularly those characterized by dysregulated protein synthesis and cellular proliferation.
